{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:25:41Z","timestamp":1786987541894,"version":"build-2736575974"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.critrevonc.2026.105161","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T07:42:55Z","timestamp":1769672575000},"page":"105161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Diagnostic and prognostic significance of circulating HPV cfDNA in cervical cancer: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"220","author":[{"given":"Preetiparna","family":"Parida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankita","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elstin Anbu","family":"Raj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyamala","family":"Guruvare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahadev","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rama Rao","family":"Damerla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5306-1649","authenticated-orcid":false,"given":"Shirley","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2026.105161_bib1","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1002\/1878-0261.13538","article-title":"Circulating cell-free HPV DNA is a strong marker for disease severity in cervical cancer","volume":"18","author":"B\u00f8nl\u00f8kke","year":"2024","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105161_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/cells11142170","article-title":"The diagnostic value of circulating cell-free HPV DNA in plasma from cervical cancer patients","volume":"11","author":"B\u00f8nl\u00f8kke","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.critrevonc.2026.105161_bib3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/2046-4053-1-2","article-title":"The nuts and bolts of PROSPERO: an international prospective register of systematic reviews","volume":"1","author":"Booth","year":"2012","journal-title":"Syst. Rev."},{"key":"10.1016\/j.critrevonc.2026.105161_bib4","doi-asserted-by":"crossref","first-page":"342","DOI":"10.4329\/wjr.v8.i4.342","article-title":"Current imaging strategies for the evaluation of uterine cervical cancer","volume":"8","author":"Bourgioti","year":"2016","journal-title":"World J. Radio."},{"key":"10.1016\/j.critrevonc.2026.105161_bib5","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.3390\/cancers15092590","article-title":"Circulating HPV DNA as a biomarker for pre-invasive and early invasive cervical cancer: a feasibility study","volume":"15","author":"Bryan","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2026.105161_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100154","article-title":"HPV ctDNA detection of high-risk HPV types during chemoradiotherapy for locally advanced cervical cancer","volume":"6","author":"Cabel","year":"2021","journal-title":"ESMO Open"},{"key":"10.1016\/j.critrevonc.2026.105161_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043393","article-title":"Human papillomavirus mutational insertion: specific marker of circulating tumor DNA in cervical cancer patients","volume":"7","author":"Campitelli","year":"2012","journal-title":"PLOS ONE"},{"key":"10.1016\/j.critrevonc.2026.105161_bib8","unstructured":"Cervical cancer [WWW Document], n.d. URL \u3008https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cervical-cancer\u3009 (accessed 1.2.26)."},{"key":"10.1016\/j.critrevonc.2026.105161_bib9","unstructured":"Cervical Cancer Diagnosis - NCI [WWW Document], 2022. URL \u3008https:\/\/www.cancer.gov\/types\/cervical\/diagnosis\u3009 (accessed 1.2.26)."},{"key":"10.1016\/j.critrevonc.2026.105161_bib10","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jcv.2019.03.005","article-title":"Liquid biopsy of HPV DNA in cervical cancer","volume":"114","author":"Cheung","year":"2019","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.critrevonc.2026.105161_bib11","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jclinepi.2005.01.016","article-title":"The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed","volume":"58","author":"Deeks","year":"2005","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.critrevonc.2026.105161_bib12","first-page":"3","article-title":"Detection and quantitation of human papillomavirus DNA in the plasma of patients with cervical carcinoma1","volume":"11","author":"Dong","year":"2002","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.critrevonc.2026.105161_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2023.105469","article-title":"The role of circulating viral and tumour DNA in the diagnosis and management of HPV associated anogenital cancers, a systematic review and meta-analysis","volume":"164","author":"Elasifer","year":"2023","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.critrevonc.2026.105161_bib14","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ygyno.2010.08.004","article-title":"Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery","volume":"119","author":"Ferrandina","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105161_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70446","article-title":"Gene-specific ctDNA dynamics predict tumour burden and survival outcomes in ESCC: a prospective cohort study","volume":"15","author":"Gu","year":"2025","journal-title":"Clin. Transl. Med"},{"key":"10.1016\/j.critrevonc.2026.105161_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.18.00152","article-title":"Circulating human papillomavirus DNA as a biomarker of response in patients with locally advanced cervical cancer treated with definitive chemoradiation","author":"Han","year":"2018","journal-title":"JCO Precis. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105161_bib17","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1200\/JCO.23.00954","article-title":"Clinical validation of human papilloma virus circulating tumor DNA for early detection of residual disease after chemoradiation in cervical cancer","volume":"42","author":"Han","year":"2024","journal-title":"JCO"},{"key":"10.1016\/j.critrevonc.2026.105161_bib18","first-page":"163","article-title":"Elevation of HPV-18 and HPV-16 DNA in the plasma of patients with advanced cervical cancer","volume":"12","author":"Jaberipour","year":"2011","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.critrevonc.2026.105161_bib19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/cjp2.47","article-title":"Circulating human papillomavirus DNA detected using droplet digital PCR in the serum of patients diagnosed with early stage human papillomavirus-associated invasive carcinoma","volume":"2","author":"Jeannot","year":"2016","journal-title":"J. Pathol. Clin. Res"},{"key":"10.1016\/j.critrevonc.2026.105161_bib20","doi-asserted-by":"crossref","first-page":"5869","DOI":"10.1158\/1078-0432.CCR-21-0625","article-title":"Circulating HPV DNA as a marker for early detection of relapse in patients with cervical cancer","volume":"27","author":"Jeannot","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105161_bib21","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.18203\/2320-1770.ijrcog20191505","article-title":"A comparison of cervical cancer screening methods: pap smear, liquid based cytology and VIA VILI","volume":"8","author":"Jeyakumar","year":"2019","journal-title":"Int. J. Reprod. Contracept. Obstet. Gynecol."},{"key":"10.1016\/j.critrevonc.2026.105161_bib22","doi-asserted-by":"crossref","first-page":"6856","DOI":"10.1158\/1078-0432.CCR-17-1553","article-title":"Circulating cell-free DNA for metastatic cervical cancer detection, genotyping, and monitoring","volume":"23","author":"Kang","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105161_bib23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ygyno.2016.10.032","article-title":"Disease courses in patients with residual tumor following concurrent chemoradiotherapy for locally advanced cervical cancer","volume":"144","author":"Kim","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105161_bib24","doi-asserted-by":"crossref","first-page":"659","DOI":"10.4143\/crt.2022.1440","article-title":"Plasma cell-free DNA in uterine cervical cancer: therapeutic monitoring and prognostic values after radical radiotherapy","volume":"55","author":"Kim","year":"2023","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.critrevonc.2026.105161_bib25","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1196\/annals.1448.009","article-title":"Circulating DNA in the blood of gastric cancer patients","volume":"1137","author":"Kolesnikova","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.critrevonc.2026.105161_bib26","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.3390\/cancers15051387","article-title":"Predicting response to radical chemoradiotherapy with circulating HPV DNA (cHPV-DNA) in locally advanced uterine cervix cancer","volume":"15","author":"Lalondrelle","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2026.105161_bib27","doi-asserted-by":"crossref","first-page":"5857","DOI":"10.1158\/1078-0432.CCR-19-2384","article-title":"HPV sequencing facilitates ultrasensitive detection of HPV circulating tumor DNA","volume":"27","author":"Leung","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"2020","key":"10.1016\/j.critrevonc.2026.105161_bib28","article-title":"Personalized and tumor informed circulating tumor DNA assay for molecular residual disease monitoring of solid malignancies","volume":"6","author":"Liu","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.critrevonc.2026.105161_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2022.105805","article-title":"Comparison of next generation sequencing, droplet digital PCR, and quantitative real-time PCR for the earlier detection and quantification of HPV in HPV-positive oropharyngeal cancer","volume":"128","author":"Mattox","year":"2022","journal-title":"Oral. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105161_bib30","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1038\/s41416-023-02233-x","article-title":"Detection of circulating cell-free HPV DNA of 13 HPV types for patients with cervical cancer as potential biomarker to monitor therapy response and to detect relapse","volume":"128","author":"Mittelstadt","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105161_bib31","first-page":"162","article-title":"Diagnostic tests: how to estimate the positive predictive value","volume":"2","author":"Molinaro","year":"2015","journal-title":"Neurooncol. Pr."},{"key":"10.1016\/j.critrevonc.2026.105161_bib32","doi-asserted-by":"crossref","first-page":"323","DOI":"10.7150\/jca.6226","article-title":"Plasma cell-free DNA in paediatric lymphomas","volume":"4","author":"Mussolin","year":"2013","journal-title":"J. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105161_bib33","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jmoldx.2023.11.007","article-title":"Comparing the diagnostic performance of quantitative PCR, digital droplet PCR, and next-generation sequencing liquid biopsies for human papillomavirus-associated cancers","volume":"26","author":"Naegele","year":"2024","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.critrevonc.2026.105161_bib34","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst. Rev."},{"key":"10.1016\/j.critrevonc.2026.105161_bib35","doi-asserted-by":"crossref","first-page":"173","DOI":"10.21873\/cgp.20029","article-title":"Next-generation sequencing (NGS) analysis on single circulating tumor cells (CTCs) with no need of whole-genome amplification (WGA)","volume":"14","author":"Palmirotta","year":"2017","journal-title":"Cancer Genom. Proteom."},{"key":"10.1016\/j.critrevonc.2026.105161_bib36","article-title":"Circulating cell-free DNA as a diagnostic and prognostic marker for cervical cancer","author":"Parida","year":"2023","journal-title":"Int. J. Gynecol. Cancer ijgc"},{"key":"10.1016\/j.critrevonc.2026.105161_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.tvr.2025.200325","article-title":"Precise identification of viral\u2013host integration events in HPV-positive cervical cancers by targeted long-read sequencing","volume":"20","author":"Parida","year":"2025","journal-title":"Tumour Virus Res."},{"key":"10.1016\/j.critrevonc.2026.105161_bib38","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1093\/clinchem\/hvaa103","article-title":"Plasma or serum: which is preferable for mutation detection in liquid biopsy?","volume":"66","author":"Pittella-Silva","year":"2020","journal-title":"Clin. Chem."},{"key":"10.1016\/j.critrevonc.2026.105161_bib39","unstructured":"PRISMA 2020 statement \u2014 PRISMA statement [WWW Document], n.d. URL \u3008https:\/\/www.prisma-statement.org\/prisma-2020\u3009 (accessed 1.2.26)."},{"key":"10.1016\/j.critrevonc.2026.105161_bib40","unstructured":"RevMan: Systematic review and meta-analysis tool for researchers worldwide | Cochrane RevMan [WWW Document], n.d. URL \u3008https:\/\/revman.cochrane.org\/info\u3009 (accessed 1.2.26)."},{"key":"10.1016\/j.critrevonc.2026.105161_bib41","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1177\/1535370220978899","article-title":"Rapid and ultrasensitive detection of circulating human papillomavirus E7 cell-free DNA as a cervical cancer biomarker","volume":"246","author":"Rungkamoltip","year":"2021","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.critrevonc.2026.105161_bib42","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/j.ijrobp.2023.06.218","article-title":"HPV circulating cell-free DNA kinetics in cervical cancer patients undergoing definitive chemoradiation","volume":"117","author":"Seo","year":"2023","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2026.105161_bib43","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/jjco\/hyp193","article-title":"Human papillomavirus DNA in plasma of patients with HPV16 DNA-positive uterine cervical cancer","volume":"40","author":"Shimada","year":"2010","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105161_bib44","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ygyno.2022.07.028","article-title":"Circulating cell-free tumor human papillomavirus DNA is a promising biomarker in cervical cancer","volume":"167","author":"Sivars","year":"2022","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105161_bib45","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1158\/1078-0432.CCR-23-3941","article-title":"Cell-free human papillomavirus DNA is a sensitive biomarker for prognosis and for early detection of relapse in locally advanced cervical cancer","volume":"30","author":"Sivars","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105161_bib46","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer Journal Clinicians"},{"key":"10.1016\/j.critrevonc.2026.105161_bib47","first-page":"20","article-title":"Efficient mutation screening for cervical cancers from circulating tumor DNA in blood","author":"Sy","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2026.105161_bib48","doi-asserted-by":"crossref","first-page":"12597","DOI":"10.1007\/s00432-023-05077-3","article-title":"Digital droplet PCR-based quantification of ccfHPV-DNA as liquid biopsy in HPV-driven cervical and vulvar cancer","volume":"149","author":"Thangarajah","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105161_bib49","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ejogrb.2024.07.036","article-title":"Prognostic value of human papillomavirus cell-free DNA in cervical cancer patients: a systematic review and meta-analysis","volume":"300","author":"Wang","year":"2024","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.critrevonc.2026.105161_bib50","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann. Intern Med."},{"key":"10.1016\/j.critrevonc.2026.105161_bib51","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.clinbiochem.2016.09.009","article-title":"Cell-free DNA in maternal plasma and serum: a comparison of quantity, quality and tissue origin using genomic and epigenomic approaches","volume":"49","author":"Wong","year":"2016","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.critrevonc.2026.105161_bib52","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1136\/ijgc-00009577-200409000-00025","article-title":"Quantification of human papillomavirus DNA in the plasma of patients with cervical cancer","volume":"14","author":"Yang","year":"2004","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105161_bib53","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.101887","article-title":"Monitoring circulating cell-free HPV DNA in metastatic or recurrent cervical cancer: clinical significance and treatment implications","volume":"13","author":"Yin","year":"2025","journal-title":"eLife"},{"key":"10.1016\/j.critrevonc.2026.105161_bib54","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-2288-6-31","article-title":"Meta-DiSc: a software for meta-analysis of test accuracy data","volume":"6","author":"Zamora","year":"2006","journal-title":"BMC Med. Res. Method."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104084282600048X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104084282600048X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T19:59:29Z","timestamp":1776974369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104084282600048X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":54,"alternative-id":["S104084282600048X"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105161","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic and prognostic significance of circulating HPV cfDNA in cervical cancer: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105161","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105161"}}